Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study.
Atsushi ObaY H A WuC H LieuC MeguidK L ColbornL BeatyM H Al-MusawiS L DavisAlexis D LealT PurcellG KingE S WootenY FujiwaraK A GoodmanT SchefterS D KaramA L GleisnerS AhrendtS LeongW A MessersmithR D SchulickM Del ChiaroPublished in: The British journal of surgery (2021)
The safety and efficacy of multiagent chemotherapy in patients aged 75 years or over were similar to those in younger patients. Modern multiagent regimens could be a safe and viable treatment option for clinically fit patients aged at least 75 years.